nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.06.2013 | Reproductive Medicine

Can ovarian damage be reduced using hemostatic matrix during laparoscopic endometrioma surgery? A prospective, randomized study

verfasst von: Murat Sönmezer, Salih Taşkın, Ali Gemici, Korhan Kahraman, Batuhan Özmen, Bülent Berker, Cem Atabekoğlu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the effect of hemostatic matrix (HM) and electrosurgical bipolar coagulation (EBC) on ovarian reserve in patients undergoing endometrioma surgery.

Methods

Thirty patients with single ovarian endometrioma ≥4 cm were randomized to two groups. Ovarian reserve after laparoscopic excision of endometrioma was assessed by serum anti-Müllerian hormone (AMH); preoperatively and in postoperative months 1 and 3.

Results

The preoperative AMH levels were similar between the groups. Intra-group comparisons: the AMH levels were significantly lower in the first and third postoperative months as compared to basal levels in both groups. In each group, AMH levels were significantly higher in the third postoperative month as compared to first postoperative month. Inter-group comparisons: AMH levels were significantly lower in the EBC as compared to the HM at 1st postoperative month (1.64 ± 0.93 vs. 2.72 ± 1.49 ng/mL). However, the AMH levels were increased and became similar at 3rd postoperative month.

Conclusions

Although acute ovarian damage was more in EBC group, ovarian reserve was compensated at 3rd month. Further studies with long-term follow-up will clarify the importance of these findings.

Kitajima M, Defrère S, Dolmans MM et al (2011) Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril 96:685–691PubMedCrossRef

Mohamed ML, Nouh AA, El-Behery MM, Mansour SA (2011) Effect on ovarian reserve of laparoscopic bipolar electrocoagulation versus laparotomic hemostatic sutures during unilateral ovarian cystectomy. Int J Gynaecol Obstet 114:69–72PubMedCrossRef

Raffi F, Metwally M, Amer S (2012) The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 97(9):3146–3154PubMedCrossRef

Celik HG, Dogan E, Okyay E, Ulukus C, Saatli B, Uysal S, Koyuncuoglu M (2012) Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimullerian hormone levels. Fertil Steril 97:1472–1478PubMedCrossRef

Ebert AD, Hollauer A, Fuhr N, Langolf O, Papadopoulos T (2009) Laparoscopic ovarian cystectomy without bipolar coagulation or sutures using a gelantine-thrombin matrix sealant (FloSeal): first support of a promising technique. Arch Gynecol Obstet 280:161–165PubMedCrossRef

Angioli R, Muzii L, Montera R et al (2009) Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol. 16(2):153–156PubMedCrossRef

Ferrero S, Venturini PL, Gillott DJ et al (2012) Hemostasis by bipolar coagulation versus suture after surgical stripping of bilateral ovarian endometriomas: a randomized controlled trial. J Min Inv Gynecol 19:722–730CrossRef

Biacchiardi CP, Piane LD, Camanni M et al (2011) Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online 23:740–746PubMedCrossRef

Hwu YM, Wu FSY, Li SH et al (2011) The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Reprod Biol Endocrinol 9:80PubMedCrossRef

10.

Ercan CM, Duru NK, Karasahin KE et al (2011) Ultrasonographic evaluation and anti-mullerian hormone levels after laparoscopic stripping of unilateral endometriomas. Eur J Obstet Gynecol Reprod Biol 158:280–284PubMedCrossRef

11.

Hirokawa W, Iwase A, Goto M et al (2011) The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 26–4:904–910CrossRef

12.

Lee DY, Kim NY, Kim MJ et al (2011) Effects of laparoscopic surgery on serum anti-mullerian hormone levels in reproductive-aged women with endometrioma. Gynecol Endocrinol 27(10):733–736PubMedCrossRef

13.

Iwase A, Hirokawa W, Goto M et al (2010) Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril 94:2846–2849PubMedCrossRef

14.

Ercan CM, Sakıncı M, Duru NK et al (2010) Antimullerian hormone levels after laparoscopic endometrioma stripping surgery. Gynecol Endocrinol 26(6):468–472PubMedCrossRef

15.

Tsolakidis D, Pados G, Vavilis D et al (2010) The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril 94:71–77PubMedCrossRef

16.

Chang HJ, Han SH, Lee JR et al (2010) Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Mullerian hormone levels. Fertil Steril 94:343–349PubMedCrossRef

17.

Somigliana E, Berlanda N, Benaglia L et al (2012) Surgical excision of endometriomas and ovarian reserve: a systematic review on serum anti mullerian hormone level modifications. Fertil Steril 98:1531–1538PubMedCrossRef

18.

Almog B, Shehata F, Suissa S et al (2011) Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95:2359–2363PubMedCrossRef

19.

Nardo LG, Gelbaya TA, Wilkinson H et al (2009) Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 92:1586–1593PubMedCrossRef

20.

Themmen AP (2005) Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 34:18–21PubMedCrossRef

21.

Durlinger ALL, Kramer P, Karels B et al (1999) Control of primordial follicle recruitment by anti- Mullerian hormone in the mouse ovary. Endocrinology 140:5789–5796PubMedCrossRef

22.

Durlinger AL, Gruijters MJ, Kramer P et al (2002) Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076–1084PubMedCrossRef

23.

Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O (2006) Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21:2223–2227PubMedCrossRef

24.

Parrott JA, Skinner MK (1999) Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 140:4262–4271PubMedCrossRef

25.

Vitt UA, McGee EA, Hayashi M, Hsueh AJW (2000) In vivo treatment with GDF9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 141:3814–3820PubMedCrossRef

26.

Nilsson E, Parrott JA, Skinner MK (2001) Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol Cell Endocrinol 25:123–130CrossRef

27.

Dissen GA, Romero C, Hirshfield AN, Ojeda SR (2001) Nerve growth factor is required for early follicular development in the mammalian ovary. Endocrinology 142:2078–2086PubMedCrossRef

28.

Sonmezer M, Gungor M, Ensari A, Ortac F (2004) Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor. Int J Gynecol Cancer 14:82–88PubMedCrossRef

29.

Barboni B, Turriani M, Galeati G et al (2000) Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 63:858–864PubMedCrossRef

30.

Bianco F, Basini G, Grasselli F (2005) Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blocker. Domest Anim Endocrinol 28:308–319PubMedCrossRef

31.

Yoshino O, Osuga Y, Koga K et al (2003) Upregulation of interleukin-8 by hypoxia in human ovaries. Am J Reprod Immunol 50:286–290PubMedCrossRef

32.

Koga K, Osuga Y, Tsutsumi O et al (2000) Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab 85:3352–3355PubMedCrossRef

33.

Bedaiwy M, El-Nashar S, El-Saman A et al (2008) Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod 23:2709–2717PubMedCrossRef

34.

35.

Yoshino O, Osuga Y, Koga K et al (2003) Upregulation of interleukin-8 by hypoxia in human ovaries. Am J Reprod Immunol 50:286–290PubMedCrossRef

36.

Titel: Can ovarian damage be reduced using hemostatic matrix during laparoscopic endometrioma surgery? A prospective, randomized study
verfasst von: Murat Sönmezer
Salih Taşkın
Ali Gemici
Korhan Kahraman
Batuhan Özmen
Bülent Berker
Cem Atabekoğlu
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2704-9

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Can ovarian damage be reduced using hemostatic matrix during laparoscopic endometrioma surgery? A prospective, randomized study